Journal Title：Molecular Therapy-methods & Clinical Development

The aim of Molecular Therapy—Methods & Clinical Development is to build upon the success of Molecular Therapy in publishing important peer-reviewed methods and procedures, as well as translational advances in the broad array of fields under the molecular therapy umbrella.

Topics of particular interest within the journal's scope include:

Gene vector engineering and production,

Methods for targeted genome editing and engineering,

Methods and technology development for cell reprogramming and directed differentiation of pluripotent cells,

Methods for gene and cell vector delivery,

Development of biomaterials and nanoparticles for applications in gene and cell therapy and regenerative medicine,

Analysis of gene and cell vector biodistribution and tracking,

Pharmacology/toxicology studies of new and next-generation vectors,

Methods for cell isolation, engineering, culture, expansion, and transplantation,

Cell processing, storage, and banking for therapeutic application,

Preclinical and QC/QA assay development,

Translational and clinical scale-up and Good Manufacturing procedures and process development,

Clinical protocol development,

Computational and bioinformatic methods for analysis, modeling, or visualization of biological data,

Negotiating the regulatory approval process and obtaining such approval for clinical trials.

《分子療法—方法與臨床發(fā)展》的目標是在《分子療法》成功的基礎(chǔ)上，發(fā)表重要的同行評審方法和程序，以及分子療法領(lǐng)域廣泛領(lǐng)域的轉(zhuǎn)化進展。

該期刊范圍內(nèi)特別感興趣的主題包括：

基因載體工程和生產(chǎn)，

靶向基因組編輯和工程方法，

細胞重編程和多能細胞定向分化的方法和技術(shù)開發(fā)，

基因和細胞載體遞送方法，

用于基因和細胞治療以及再生醫(yī)學應用的生物材料和納米顆粒的開發(fā)，

基因和細胞載體生物分布和追蹤分析，

新一代和下一代載體的藥理學/毒理學研究，

細胞方法分離、工程、培養(yǎng)、擴增和移植，

用于治療應用的細胞處理、儲存和儲存，

臨床前和 QC/QA 檢測開發(fā)，

轉(zhuǎn)化和臨床擴大以及良好生產(chǎn)程序和工藝開發(fā)，

臨床方案開發(fā)，

用于分析、建?；蚩梢暬飻?shù)據(jù)的計算和生物信息學方法，

協(xié)商監(jiān)管審批流程并獲得臨床試驗批準。

Molecular Therapy-methods & Clinical Development創(chuàng)刊于2014年，由Cell Press出版商出版，收稿方向涵蓋Biochemistry, Genetics and Molecular Biology - Molecular Biology全領(lǐng)域，此刊是該細分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細分領(lǐng)域中學術(shù)影響力較大，專業(yè)度認可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 12 Weeks ，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。